Intelligence / BPC-157

BPC-157

Prescription Only
Tissue Repair
Schedule
S4
Prescription Only
Enforcement
Stable
Low Risk
Providers
18
Access: Clear
Key Facts
Schedule 4 - Prescription Only
15 amino acid synthetic peptide
18 identified Australian providers
Stable regulatory environment
Widely compounded in Australia

Overview

BPC-157 is a synthetic peptide consisting of 15 amino acids, derived from a protein found in human gastric juice. It is one of the most widely prescribed peptides in Australia, available through compounding pharmacies with a valid prescription.

Australian Scheduling

Classified as Schedule 4 (Prescription Only) under the Poisons Standard. Requires a valid prescription from an AHPRA-registered medical practitioner. No anticipated scheduling changes for 2026-2027.

Access Pathway

Available through most telehealth peptide clinics and compounding pharmacies nationally. This is one of the most accessible prescription peptides in the Australian market, with 18 identified providers offering consultations.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

News & Updates20 items
BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence
Int J Mol Sci19 Sept 2026
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
Missouri medicine18 Sept 2026
Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards.
International journal of pharmaceutical compounding17 Sept 2026
Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery trial posted on ClinicalTrials.gov
ClinicalTrials.gov3 Sept 2026
The peptide surge has reached compounding
Australian Pharmacist31 Aug 2026
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.
Applied biochemistry and biotechnology29 Aug 2026
Peptides: what's behind the hype?
Alcohol and Drug Foundation27 Aug 2026
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Current pain and headache reports24 Aug 2026
Meet the doctors prescribing experimental peptides such as TB-500 and BPC-157 to athletes and executives
Australian Financial Review16 Aug 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
The American journal of sports medicine11 Aug 2026
DIY peptide injections are risky, and people may make serious mistakes when administering them
The Conversation7 Aug 2026
A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery trial posted on ClinicalTrials.gov
ClinicalTrials.gov7 Aug 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society29 July 2026
FDA panel votes to loosen restrictions for controversial peptides
BBC News23 July 2026
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
Joint diseases and related surgery23 July 2026
Unapproved peptide product promoters and suppliers are put on notice
TGA20 July 2026
Unapproved SARMs found to be significantly underdosed
TGA6 July 2026
Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.
3 Biotech6 July 2026
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review
Current sports medicine reports1 July 2026
TGA and Chief Medical Officer issue joint statement on unapproved peptide products
TGA20 June 2026

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.